50th HEIDELBERG GRAND ROUNDS NeuroOncology at the Limits Chairs: December 9th, 2015 Prof. Dr. Wolfgang Wick 16.00 – 18.00 Prof. Dr. Michael Platten Lecture Hall, DKFZ Please register by 8th December Information and registration: Marketing sponsored by: at the latest. Fortbildungs- und Veranstaltungs- organisation des Nationalen Centrums Roche Pharma AG 1.000€ For this event, two points for für Tumorerkrankungen MSD Sharp & Dohme GmbH 800€ continuing education will be given Heidelberg School of Oncology Mundipharma GmbH 500€ by the Landesärztekammer. Im Neuenheimer Feld 460 Within the practical year, the points 69120 Heidelberg will be recognized in the field of Phone +49 (0)6221.566558 internal medicine and surgery. Fax +49 (0)6221.565094 [email protected] http://www.nct-heidelberg.de/nc/das-nct/veranstaltungen/anmeldung.html Then don‘t miss the far away? Too LIVE-VIDEO- STREAMING 50th HEIDELBERG GRAND ROUNDS on 9th December 2015, 16:00 – 18:00 I will participate. Person/s will accompany me. Fortbildungs- und Veranstaltungs- If not participating no reply necessary. organisation des Nationalen Centrums Name für Tumorerkrankungen Heidelberg School of Oncology First name Im Neuenheimer Feld 460 Location/street 69120 Heidelberg Signature (registration via fax: 06221.565094) 50th HEIDELBERG GRAND ROUNDS Heidelberg Grand Rounds (HGR) Michelle Monje, MD, oncology and a postdoctoral fellowship. The “Ground Rules” PhD joined the faculty scope of her research program encompasses The HGR have been established at Stanford University the molecular determinants of neural precur- as a forum to bring together in 2011 as an Assistant sor cell fate, neuronal-glial interactions, and basic scientists and clinicians. Professor of Neurology the role of neural precursor cells in oncogen- Distinguished experts present and Neuro-Oncology. esis and repair mechanisms. As a practicing novel clinical and research findings Following her under- neurologist and neuro-oncologist, Dr. Monje and provide a comprehensive graduate degree in is dedicated to understanding the neurode- update in the respective field of biology at Vassar velopmental origins of pediatric brain tumors oncology. College, Dr. Monje and the neurological consequences of cancer received her MD and treatment. In addition to the high-ranking PhD in Neuroscience from Stanford University. scientific and clinical presentations, She then completed neurology residency at the HGR also constitute a casual the Massachusetts General Hospital/Brigham get-together, seasoned with drinks and Women’s Hospital/Harvard Medical School and refreshments, to foster a program. She subsequently returned to Stan- lively atmo sphere for continued ford for a clinical fellowship in pediatric neuro- discussion. NeuroOncology at the Limits Dr. David T. W. Jones Next Generation Molecular Diagnostics German Cancer Research Center, Dept. of Paediatric Neurooncology, Heidelberg Prof. Dr. Frank Winkler Astrocytomas are Multicellular Networks Neurology Clinical Heidelberg, University Medical Center and Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg Prof. Dr. Michelle Monje-Deisseroth Brain-Glioma-Interface Head of Monje Lab of Neurology and Neurological Sciences, Assistant Professor of Neurology, and by courtesy, Neurosurgery, Pathology and Pediatrics, Stanford University Prof. Dr. Michael Platten Using the Immune System for Brain Tumor Therapy Neurology Clinic Heidelberg, University Medical Center and Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg Prof. Dr. Wolfgang Wick Heidelberg Concepts and Pitfalls of molecular- Neurology Clinic Heidelberg, University Medical Center and Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg based trials .